EARLY ON-TREATMENT RESPONSES DURING PEGYLATED IFN PLUS RIBAVIRIN ARE INCREASED FOLLOWING 13 DAYS OF COMBINATION NUCLEOSIDE POLYMERASE (RG7128) AND PROTEASE (RG7227) INHIBITOR THERAPY (INFORM-1)

被引：6

作者：

Gane, E. ^{[1
]}

Roberts, S. ^{[2
]}

Stedman, C. ^{[3
]}

Angus, P. ^{[4
]}

Ritchie, B. ^{[5
]}

Elston, R. ^{[6
]}

Ipe, D. ^{[6
]}

Morcos, P. ^{[6
]}

Baher, L. ^{[6
]}

Najera, I. ^{[6
]}

Chu, T. ^{[6
]}

Mannino, M. ^{[6
]}

Berry, M. ^{[7
]}

Bradford, W. ^{[8
]}

Laughlin, M. ^{[6
]}

Shulman, N. ^{[6
]}

Smith, P. ^{[6
]}

机构：

[1] Auckland Clin Studies, Auckland, New Zealand

[2] Alfred Hosp, Melbourne, Vic, Australia

[3] Christchurch Clin Studies, Christchurch, New Zealand

[4] Austin Hosp, Melbourne, Vic 3084, Australia

[5] Royal Adelaide Hosp, Adelaide, SA 5000, Australia

[6] Roche Palo Alto LLC, Palo Alto, CA USA

[7] Pharmasset Inc, Princeton, NJ USA

[8] InterMune Inc, Brisbane, CA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(10)60751-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S291 / S292

页数：2